2.10
price up icon1.45%   0.03
pre-market  Vorhandelsmarkt:  2.15   0.05   +2.38%
loading
Schlusskurs vom Vortag:
$2.07
Offen:
$2.07
24-Stunden-Volumen:
654.22K
Relative Volume:
0.63
Marktkapitalisierung:
$101.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-97.22M
KGV:
-1.5217
EPS:
-1.38
Netto-Cashflow:
$-82.44M
1W Leistung:
-2.78%
1M Leistung:
+1.45%
6M Leistung:
-23.64%
1J Leistung:
-78.06%
1-Tages-Spanne:
Value
$2.04
$2.125
1-Wochen-Bereich:
Value
$2.04
$2.21
52-Wochen-Spanne:
Value
$1.15
$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Name
Firmenname
Cassava Sciences Inc
Name
Telefon
512-501-2444
Name
Adresse
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Name
Mitarbeiter
30
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
SAVA's Discussions on Twitter

Vergleichen Sie SAVA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SAVA
Cassava Sciences Inc
2.10 104.35M 0 -97.22M -82.44M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.27 123.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
550.00 60.43B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.69 42.07B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
572.71 34.47B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.35 27.42B 3.81B -644.79M -669.77M -6.24

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-26 Herabstufung H.C. Wainwright Buy → Neutral
2024-10-08 Hochstufung H.C. Wainwright Neutral → Buy
2024-07-01 Herabstufung H.C. Wainwright Buy → Neutral
2022-11-16 Herabstufung B. Riley Securities Buy → Neutral
2021-07-15 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-07-07 Bestätigt Maxim Group Buy
2021-04-27 Eingeleitet B. Riley Securities Buy
2021-02-16 Bestätigt H.C. Wainwright Buy
2020-10-23 Eingeleitet Cantor Fitzgerald Overweight
2020-09-23 Hochstufung H.C. Wainwright Neutral → Buy
2020-05-18 Herabstufung H.C. Wainwright Buy → Neutral
2020-05-15 Herabstufung Maxim Group Buy → Hold
2020-01-10 Bestätigt Maxim Group Buy
Alle ansehen

Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten

pulisher
Jul 04, 2025

SAVA STOCK ALERT: Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of an Ongoing Investigation - ACCESS Newswire

Jul 04, 2025
pulisher
Jul 02, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Cassava Sciences, Inc. to Contact the Firm Today! - ACCESS Newswire

Jul 02, 2025
pulisher
Jun 30, 2025

Cassava Sciences, Inc.(NasdaqCM:SAVA) dropped from Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting - GlobeNewswire

Jun 30, 2025
pulisher
Jun 30, 2025

Cassava Sciences reports simufilam reduced seizures in mouse model - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Cassava Sciences Reveals Promising Simufilam Preclinical Data - TipRanks

Jun 30, 2025
pulisher
Jun 25, 2025

Is Cassava Sciences, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 10, 2025

Shareholders Filed a Lawsuit Against Cassava Sciences for Misleading Alzheimer’s Drug Claims - TradingView

Jun 10, 2025
pulisher
Jun 06, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit! - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Sold by Cetera Investment Advisers - Defense World

Jun 03, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Buys 55,813 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

May 31, 2025
pulisher
May 30, 2025

Cassava Sciences, Inc. (NASDAQ:SAVA) Stake Lifted by Northern Trust Corp - Defense World

May 30, 2025
pulisher
May 28, 2025

Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha

May 28, 2025
pulisher
May 27, 2025

Cassava Sciences Holds 2025 Annual Meeting, Elects Directors - TipRanks

May 27, 2025
pulisher
May 23, 2025

Transcript : Cassava Sciences, Inc.Shareholder/Analyst Call - marketscreener.com

May 23, 2025
pulisher
May 14, 2025

Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSAVA - ACCESS Newswire

May 14, 2025
pulisher
May 12, 2025

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

May 12, 2025
pulisher
May 12, 2025

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

May 12, 2025
pulisher
May 12, 2025

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - ACCESS Newswire

May 12, 2025
pulisher
May 11, 2025

Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 11, 2025
pulisher
May 10, 2025

Shareholders of Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Cassava Reports Q1 2025 Financials Results, Provides Business Update - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Cassava Sciences Shifts Focus to TSC-Related Epilepsy - TipRanks

May 09, 2025
pulisher
May 08, 2025

Cassava Sciences (SAVA) Faces Financial Challenges Amid Strategic Shifts - GuruFocus

May 08, 2025
pulisher
May 06, 2025

Invesco Ltd. Trims Stock Position in Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

May 06, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Cassava Sciences (SAVA) Appoints New SVP of Neuroscience | SAVA Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC - citybiz

May 01, 2025
pulisher
Apr 27, 2025

ATTENTION Cassava Sciences, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 27, 2025

Finanzdaten der Cassava Sciences Inc-Aktie (SAVA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
Kapitalisierung:     |  Volumen (24h):